US Patent Issued to ZOLL Medical on July 8 for "Using PH and SMO2 from a spectral sensor as an indication of subject down time" (Massachusetts Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,012, issued on July 8, was assigned to ZOLL Medical Corp. (Chelmsford, Mass.).

"Using PH and SMO2 from a spectral sensor as an indication of subject down time" was invented by Gary A. Freeman (Waltham, Mass.), Ulrich Herken (Medford, Mass.), Christopher L. Kaufman (Somerville, Mass.) and Annemarie Elizabeth Silver (Bedford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure relate generally to the use of spectral sensors during a cardiac arrest event. More specifically, the present disclosure relates to the use of spectral sensors for measuring changes in pH and muscle oxygen saturation to estimate subject down...